Phyllodes tumors, varying from benign to malignant, need precise diagnosis and surgery, with a focus on multidisciplinary ...
Chef Joey Maggiore, his family, and the teams at The Mexicano in Phoenix and The Italiano in Scottsdale are launching a ...
Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...
Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients with mCRPCInitiating ...
In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.
HealthDay on MSN6 天
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DMGLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin ...
In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.
The Fellows of the AACR Academy have elected Elaine V. Fuchs, PhD, FAACR, as their next President. She will assume the ...
Myeloproliferative neoplasms are a group of rare blood cancers that affect the bone marrow leading to abnormal cell growth that can lead to an increase in the number of red blood cells, white blood ...
Appendix tumors should be evaluated separately and not included in colon or colorectal cancer categories,” researchers concluded.
Cardiac and major vascular surgeries are intricate and high-risk procedures known for significant morbidity and mortality ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果